Craneware (CRWRF) Stock Price, News & Analysis

Company Overview

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers Trisus Decision Support; Trisus Labor Productivity; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, it offers appeal, professional, and pharmacy professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Key Stats

• Today's Range: $27.32 to $27.32
• 50-Day Range: $24.25 to $27.32
• 52-Week Range: $23.86 to $30.00
• Volume: N/A
• Average Volume: 388 shs
• Market Capitalization: N/A
• P/E Ratio: 86.18
• Dividend Yield: 0.72%
• Price Target: N/A
• Consensus Rating: N/A

Craneware Stock Analysis - MarketRank™

Craneware scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Craneware.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Craneware is 86.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.25.

Price to Earnings Ratio vs. Sector

The P/E ratio of Craneware is 86.18, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.09.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Craneware has a short interest ratio ("days to cover") of 5.

Change versus previous month

Short interest in Craneware has recently increased by 66.67%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Craneware pays a meaningful dividend of 2.44%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Craneware does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Craneware is 62.40%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Craneware has a short interest ratio ("days to cover") of 5.

Change versus previous month

Short interest in Craneware has recently increased by 66.67%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Craneware has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Craneware this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Craneware insiders have not sold or bought any company stock.

Percentage Held by Institutions

48.19% of the stock of Craneware is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CRWRF Stock Analysis - Frequently Asked Questions

How have CRWRF shares performed this year?

Craneware's stock was trading at $27.80 on January 1st, 2025. Since then, CRWRF stock has decreased by 1.7% and is now trading at $27.32.
View the best growth stocks for 2025 here.

How do I buy shares of Craneware?

Shares of CRWRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CRWRF
• CIK: N/A
• Web: www.thecranewaregroup.com
• Phone: 441315503100
• Fax: N/A
• Employees: 734
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 86.18
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A